NASDAQ:INCY • US45337C1027
This INCY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
Taking everything into account, INCY scores 7 out of 10 in our fundamental rating. INCY was compared to 519 industry peers in the Biotechnology industry. Both the health and profitability get an excellent rating, making INCY a very profitable company, without any liquidiy or solvency issues. INCY is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, INCY could be worth investigating further for value and quality investing!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.49% | ||
| ROE | 24.9% | ||
| ROIC | 19.49% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.12% | ||
| PM (TTM) | 25.03% | ||
| GM | 93.26% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Altman-Z | 8.5 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.32 | ||
| Quick Ratio | 3.25 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.3 | ||
| Fwd PE | 12.68 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.27 | ||
| EV/EBITDA | 10.65 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
97.1
+1.16 (+1.21%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.3 | ||
| Fwd PE | 12.68 | ||
| P/S | 3.76 | ||
| P/FCF | 14.27 | ||
| P/OCF | 13.67 | ||
| P/B | 3.74 | ||
| P/tB | 3.93 | ||
| EV/EBITDA | 10.65 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.49% | ||
| ROE | 24.9% | ||
| ROCE | 24.67% | ||
| ROIC | 19.49% | ||
| ROICexc | 56.96% | ||
| ROICexgc | 65.8% | ||
| OM | 26.12% | ||
| PM (TTM) | 25.03% | ||
| GM | 93.26% | ||
| FCFM | 26.35% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Debt/EBITDA | 0.02 | ||
| Cap/Depr | 63.1% | ||
| Cap/Sales | 1.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 98.43% | ||
| Profit Quality | 105.28% | ||
| Current Ratio | 3.32 | ||
| Quick Ratio | 3.25 | ||
| Altman-Z | 8.5 |
ChartMill assigns a fundamental rating of 7 / 10 to INCY.
ChartMill assigns a valuation rating of 7 / 10 to INCYTE CORP (INCY). This can be considered as Undervalued.
INCYTE CORP (INCY) has a profitability rating of 9 / 10.
The financial health rating of INCYTE CORP (INCY) is 7 / 10.
The Earnings per Share (EPS) of INCYTE CORP (INCY) is expected to grow by 12.8% in the next year.